Description
VISTARIC 40MG by Genesis Biotec is formulated with Febuxostat (40 mg), a powerful xanthine oxidase inhibitor designed to reduce elevated levels of uric acid in the bloodstream. It is primarily prescribed for the long-term management of hyperuricemia in individuals with gout. By inhibiting the xanthine oxidase enzyme, Febuxostat helps prevent the formation of uric acid crystals, thereby reducing the risk of gout flare-ups and associated joint pain or inflammation.
This medication is suitable for patients intolerant to or inadequately treated with allopurinol. Regular use of VISTARIC 40MG, as directed by a healthcare professional, helps maintain healthy uric acid levels and improves the quality of life for gout patients.
